Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States
Rishi Desai, Ameet Sarpatwari, Nileesa Gautam, Joyce Lii, Michael A. Fischer, Joshua J. Gagne
Abstract
This pharmacoepidemiology study uses claims data to characterize angiotensin receptor blocker (ARB) prescription trends to evaluate whether recalls of ARBs prompted by discovery of potentially carcinogenic impurities shifted utilization of ARBs individually and as a drug class.
Topics & Concepts
MedicinePharmacoepidemiologyAngiotensin Receptor BlockersMedical prescriptionPharmacologyAngiotensin receptorAngiotensin IIDrugReceptorInternal medicineRenin–angiotensin systemBlood pressurePharmaceutical industry and healthcareHealth Systems, Economic Evaluations, Quality of LifePharmacovigilance and Adverse Drug Reactions